Exploring Treatment Strategies for Lymphoma: CAR T-Cell, Tafasitamab, and Clinical Trials

News
Video

An in-depth examination of relapsed/refractory DLBCL treatment options, including CAR T-cell therapy and tafasitamab, based on clinical trial data and patient eligibility.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
1 expert in this video
1 expert in this video
1 expert in this video
Related Content